OpenAlex
PricingAboutJobs
Log inGet started
Work

A prospective trial of midwest breast cancer patients: Ap53 gene mutation is the most important predictor of adverse outcome

HTML

Year: 2000
Type: article
Study design: Observational Study
Source: International Journal of Cancer
DOI: 10.1002/(sici)1097-0215(20000120)89:1<32::aid-ijc6>3.0.co;2-g
Authors: Hagen Blaszyk, Arndt Hartmann, Julie M. Cunningham, Daniel Schaid, Lester E. Wold, John S. Kovach, Steve S. Sommer
Institution: Mayo Clinic
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: TP53 mutation, breast cancer, prognostic factors, tumor recurrence, treatment failure, adjuvant therapy response, palliative care, survival, mutation detection
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: G142300368, P53 BREAST CANCER MUTATIONS IN HIGH AND LOW RISK GROUPS
OpenAlex ID: W2047400342
FWCI: 2.004
Cites: 41
Cited by: 61
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms